1. [Home](https://www.g2.com/) 2. ... 3. [Other Healthcare Services Providers](https://www.g2.com/categories/other-healthcare-services) 4. [bioaccess Discussions](https://www.g2.com/products/bioaccess/discuss) [ ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_cadcd8ad91821468bf36614793485a38/bioaccess.jpg "Product Avatar Image") ](/products/bioaccess/reviews) [ bioaccess ](/products/bioaccess/reviews) 0 ratings bioaccess® is the world's first and only CRO purpose-built for first-in-human clinical trials — serving MedTech, biopharma, and radiopharma startups across Latin America and beyond. While traditional CROs offer FIH as one of dozens of services buried in an enterprise menu, bioaccess® was founded for this singular mission: getting breakthrough healthcare innovations into human trials faster, at lower cost, and with investor-ready data from day one. Healthcare startups developing breakthrough MedTech devices, Biopharma therapeutics, and Radiopharma treatments face a critical bottleneck: generating the clinical data investors and acquirers demand — before the money runs out. Traditional CROs are built for big pharma running Phase III mega-trials. They move slowly, charge premium rates, and treat early-stage startups as an afterthought. The result? Promising innovations die in the valley of death — not because the science failed, but because the clinical pathway took too long and cost too much. bioaccess® was founded in 2010 to solve this exact problem. We are the world's first and only contract research organization built from day one exclusively around first-in-human clinical trials for healthcare startups. We created a new category in clinical research — one that matches the speed, urgency, and capital constraints of founders raising rounds, engaging strategic acquirers, and racing toward exits. Who We Serve: Seed-stage to growth-stage startups across MedTech, Biopharma, and Radiopharma — companies that need human proof-of-concept data to unlock their next milestone. What Makes Us Different: Through our proprietary Innovation Runway — the world's first clinical development pathway built exclusively for FIH trials — we deliver ethics approval in 4–8 weeks, compress timelines by 40%, and reduce costs by 30% compared to US/EU-only approaches. Every study is 100% ICH-GCP aligned, producing FDA/EMA-ready data with no rework required. We operate across 10 countries in Latin America, including Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, and Paraguay — giving startups access to treatment-naive patient cohorts enrolled 50% faster than US sites. Since 2010, bioaccess® has accelerated 58+ companies from seed-stage startups to Fortune 500 MedTech — proving that the fastest path from prototype to clinical milestones runs through Latin America. Headquartered in Miami, FL. Learn more at bioaccessla.com. Show More When users leave bioaccess reviews, G2 also collects common questions about the day-to-day use of bioaccess. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion. * * * ### 0.0 Nps Score ### All bioaccess Discussions Search Most CommentedMost HelpfulPinned by G2Newest All DiscussionsDiscussions with CommentsPinned by G2Discussions without Comments FilterFilter Filter byExpand/Collapse Sort by Most Commented Most Helpful Pinned by G2 Newest Filter by All Discussions Discussions with Comments Pinned by G2 Discussions without Comments Sorry... There are no questions about bioaccess yet. ## Start a New Software Discussion Have a software question? Get answers from real users and experts [Start A Discussion](/products/bioaccess/discussions/new) * * * ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_cadcd8ad91821468bf36614793485a38/bioaccess.jpg "Product Avatar Image") ### Have you used bioaccess before? Answer a few questions to help the bioaccess community [ Yes ](javascript:void(0))[ Yes ](https://www.g2.com/authorize?form=signup&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fbioaccess%2Fdiscuss%3Fsmall_ask%3Dbioaccess) No